类风湿性关节炎中的天然产品:细胞类型特异性机制和治疗含义
Yang Liao1, Xian Xiao1, Wen Cheng2
1The Second Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou 510405, China; State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
概括
传统中医的天然产品在类风湿性关节炎 (RA) 发病过程中准特定的细胞. 本综述详细介绍了它们的细胞类型特异性抗炎作用,推进了RA的精密植物医学.
科学领域:
- 综合医学和免疫学
- 药理学和天然产品研究.
- 风湿病学和细胞生物学
背景情况:
- 类风湿性关节炎 (RA) 的发病过程涉及复杂的细胞相互作用.
- 传统中医 (TCM) 的天然产品提供了多目标的抗炎潜力.
- 在RA中TCM的特定细胞影响需要详细的研究.
研究的目的:
- 综合审查天然产品对类型关键细胞在类风湿性关节炎 (RA) 的影响.
- 阐明RA中自然产品治疗潜力的细胞机制.
主要方法:
- 在PubMed,Web of Science和Scopus数据库中的系统文献搜索.
- 包括分析天然产品对RA相关细胞影响的研究.
- 分析重点是细胞机制和细胞类型的特异性.
主要成果:
- 关于RA中自然产物机制的第一个综合细胞分辨率审查.
- 西诺因通过TLR4/MyD88/NF-κB通路抑制纤维细胞样同胞细胞 (FLS).
- 伊卡林通过ERK/HIF-1α/GLUT1信号重新编程巨细胞;白醇影响多种细胞类型.
结论:
- 在RA中,天然产品表现出细胞类型特异性和全细胞效应.
- 这一审查为开发选择性RA疗法建立了框架.
- 推进RA治疗的精确植物医学和翻译研究.
相关概念视频
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Connective Tissue Cell Types
3.5K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
240
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
240
Inflammatory Response
8.5K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
8.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
278
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
278


